Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9095146 | Journal of Cardiothoracic and Vascular Anesthesia | 2005 | 7 Pages |
Abstract
Conclusions: The results fail to demonstrate the efficacy of zoniporide in reducing the proportion of patients at high risk undergoing noncardiac vascular surgery who experience a composite cardiovascular endpoint, which led the corporate sponsor to stop enrollment early on the basis of a futility analysis of the chance of demonstrating efficacy with a larger sample size.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Lee A. (FACC), Mark F. MD, Lisa B. DVM, MPVM, Anne B. PhD, C. Bill PhD, Sharon MD, William C. MD, Don MD, PhD, Roman MD, Adamastor H. MD, PhD, Pierre MD,